Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Extends Listing Deadline for Pressure BioSciences

NEW YORK (GenomeWeb News) – A Nasdaq panel has granted Pressure BioSciences' request for continued listing on the exchange, the company said today.

The Nasdaq Listing Qualifications Panel told Pressure Bio of its decision on Dec. 7 to allow the company to remain listed on the Nasdaq Capital Market until Feb. 29, 2012, subject to certain conditions, including the company's demonstration of compliance with a listing requirement to have at least $2.5 million in stockholder equity.

Pressure Bio was originally warned by Nasdaq in April that it was in danger of being delisted because of its failure to meet that requirement, and had until June to regain compliance.

The deadline was then extended to October, and after the company failed to regain compliance it requested a hearing with the Nasdaq panel.

Pressure Bio faces possible delisting action on another requirement calling for a minimum bid price on its shares of $1 for at least 30 consecutive business days. It has until Feb. 13, 2012 to regain compliance with that condition.

Faced with an evaporating cash position, the South Easton, Mass.-based firm earlier this week filed a registration form with the US Securities and Exchange Commission to raise up to $8 million.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.